New supply for the German market
Rua Bioscience strengthens supply chain into German medicinal cannabis market.
Tell Parliament: Decriminalise
Record quarterly revenue
Quarterly revenue is a record for Rua Bioscience. Sales revenue is growing significantly.
Rights issue offer
Introducing the Oleo Panacea Dry Herb Vaporiser
Oleo Panacea dry herb vaporiser available for medicinal cannabis therapy in Aotearoa New Zealand
Developed as a purpose-built inhalation device, the Oleo Panacea delivers consistent, combustion-free vapour for patients prescribed dried cannabis flower.
Record sales month in New Zealand and Australia
Annual Report and Shareholder Meeting
Product into Czechia is a major European milestone
Rua Bioscience is proud to announce our launch into the Czech market, marking a major milestone in our mission to transform lives through accessible health care and medicinal cannabis products. This expansion reflects our unwavering commitment to leveraging our extensive networks and deep industry expertise to enter diverse markets around the globe. By bridging innovation with compassionate care, we're paving new pathways to wellness, delivering trusted solutions to those who need them most. The Czech market launch is not just growth—it’s a bold step forward in reshaping health landscapes and empowering communities through every connection we make.
FY25 Annual results
Kiwi grown products in Germany
European demand is strong
The European markets of Germany, United Kingdom and Czechia for teh medicinal cannabis is growing strongly and creating opportunites for Rua Bioscience.
Record sales
Record NZ sales in March
Half year results: Global growth
Sales exceed forecast
Psilocybin clinical trial update
Happy new year
Launch of Products in the UK
